Antihemophilic factor VIII (Eloctate®)

OFFICE ADMINISTRATION / HOME HEALTH

Indications for Prior Authorization:

  • Adults and children with hemophilia.
  • A for control and prevention of bleeding episodes, perioperative management and routine prophylaxis

The following indications do not meet the criteria for use established by the Western Health Advantage Pharmacy and Therapeutics Committee:

  • Any other diagnosis not listed in the approved indications

Dosing:

  • Routine prophylaxis: 50 IU/Kg every 4 days
  • Adjust dose based on response

Monitoring

  • Half-life in children less than 6 is shorter and they may require larger doses or more frequent administration.

 

Last review date: August 4, 2014

WHA is closely monitoring the Coronavirus Disease 2019 (COVID-19). Learn more about COVID-19.